MacroGenics Inc
NASDAQ:MGNX

Watchlist Manager
MacroGenics Inc Logo
MacroGenics Inc
NASDAQ:MGNX
Watchlist
Price: 1.37 USD -0.72% Market Closed
Market Cap: 86.7m USD

Relative Value

The Relative Value of one MGNX stock under the Base Case scenario is hidden USD. Compared to the current market price of 1.37 USD, MacroGenics Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

MGNX Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
90
vs Industry
87
Median 3Y
2.2
Median 5Y
3.4
Industry
7.9
Forward
0.7
vs History
vs Industry
7
Median 3Y
-2.2
Median 5Y
-2.8
Industry
24
Forward
-1.1
vs History
vs Industry
1
Median 3Y
-2.5
Median 5Y
-3.9
Industry
21.6
vs History
vs Industry
1
Median 3Y
-2.4
Median 5Y
-3.8
Industry
23.7
vs History
93
vs Industry
61
Median 3Y
2.1
Median 5Y
2.6
Industry
3.4
vs History
vs Industry
63
Median 3Y
0.4
Median 5Y
1.7
Industry
8.3
Forward
-0.5
vs History
vs Industry
62
Median 3Y
0.4
Median 5Y
1.3
Industry
10.3
vs History
9
vs Industry
19
Median 3Y
-0.6
Median 5Y
-1.2
Industry
6.7
Forward
0.8
vs History
7
vs Industry
18
Median 3Y
-0.6
Median 5Y
-1.2
Industry
7.2
Forward
0.7
vs History
15
vs Industry
18
Median 3Y
-0.7
Median 5Y
-1.6
Industry
8.2
vs History
15
vs Industry
15
Median 3Y
-0.6
Median 5Y
-1.5
Industry
6.7
vs History
vs Industry
44
Median 3Y
1
Median 5Y
2
Industry
5.7

Multiples Across Competitors

MGNX Competitors Multiples
MacroGenics Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
MacroGenics Inc
NASDAQ:MGNX
86.7m USD 0.7 -1.1 0.9 0.8
FR
Pharnext SCA
OTC:PNEXF
6T USD 34 079 720.5 -161 975.9 -196 690.4 -194 445.9
US
Abbvie Inc
NYSE:ABBV
399.6B USD 6.7 170.2 16.5 23.4
US
Amgen Inc
NASDAQ:AMGN
177.5B USD 4.9 25.3 18.3 18.3
US
Gilead Sciences Inc
NASDAQ:GILD
150.6B USD 5.2 18.6 12.5 12.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.7B USD 9.9 31.5 23.1 24.1
US
Epizyme Inc
F:EPE
94.1B EUR 2 067.2 -527.5 -574.4 -559.1
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
75.6B USD 5.3 16.5 15.7 17.8
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
60.4B USD 18.8 1 385.9 182.8 221.7
AU
CSL Ltd
ASX:CSL
89.1B AUD 3.8 19.7 13.2 16.5
NL
argenx SE
XBRU:ARGX
47.2B EUR 15.2 35.8 62 63.7
P/S Multiple
Revenue Growth P/S to Growth
US
MacroGenics Inc
NASDAQ:MGNX
Average P/S: 3 098 350.7
0.7
-25%
N/A
FR
Pharnext SCA
OTC:PNEXF
34 079 720.5
N/A N/A
US
Abbvie Inc
NYSE:ABBV
6.7
9%
0.7
US
Amgen Inc
NASDAQ:AMGN
4.9
5%
1
US
Gilead Sciences Inc
NASDAQ:GILD
5.2
4%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
9.9
10%
1
US
E
Epizyme Inc
F:EPE
2 067.2
N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.3
6%
0.9
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
18.8
46%
0.4
AU
CSL Ltd
ASX:CSL
3.8
5%
0.8
NL
argenx SE
XBRU:ARGX
15.2
49%
0.3
P/E Multiple
Earnings Growth PEG
US
MacroGenics Inc
NASDAQ:MGNX
Average P/E: 212.9
Negative Multiple: -1.1
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -161 975.9 N/A N/A
US
Abbvie Inc
NYSE:ABBV
170.2
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
25.3
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
18.6
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
31.5
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -527.5 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.5
9%
1.8
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 385.9
N/A N/A
AU
CSL Ltd
ASX:CSL
19.7
11%
1.8
NL
argenx SE
XBRU:ARGX
35.8
40%
0.9
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
MacroGenics Inc
NASDAQ:MGNX
Average EV/EBITDA: 38.3
0.9
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -196 690.4 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.5
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
18.3
11%
1.7
US
Gilead Sciences Inc
NASDAQ:GILD
12.5
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.1
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -574.4 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.7
11%
1.4
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
182.8
N/A N/A
AU
CSL Ltd
ASX:CSL
13.2
8%
1.7
NL
argenx SE
XBRU:ARGX
62
807%
0.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
MacroGenics Inc
NASDAQ:MGNX
Average EV/EBIT: 44.3
0.8
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 445.9 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.4
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
18.3
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.5
12%
1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.1
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -559.1 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.8
13%
1.4
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
221.7
N/A N/A
AU
CSL Ltd
ASX:CSL
16.5
11%
1.5
NL
argenx SE
XBRU:ARGX
63.7
N/A N/A